Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,462 | 106 | 92.5% |
| Education | $199.94 | 2 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $527.37 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $271.65 | 9 | $0 (2024) |
| Genentech USA, Inc. | $198.09 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $183.35 | 9 | $0 (2024) |
| Amgen Inc. | $174.74 | 3 | $0 (2022) |
| Foundation Medicine, Inc. | $129.02 | 2 | $0 (2023) |
| PFIZER INC. | $118.81 | 2 | $0 (2024) |
| ABBVIE INC. | $116.04 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $106.72 | 5 | $0 (2024) |
| GENZYME CORPORATION | $103.67 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,360 | 60 | Janssen Biotech, Inc. ($228.08) |
| 2023 | $890.64 | 33 | Janssen Biotech, Inc. ($232.84) |
| 2022 | $88.16 | 5 | Janssen Biotech, Inc. ($44.94) |
| 2021 | $323.54 | 10 | Amgen Inc. ($148.53) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.61 | General |
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: Oncology | ||||||
| 10/27/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Oncology | ||||||
| 10/04/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/03/2024 | SERVIER PHARMACEUTICALS LLC | IDHIFA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Hematology/Oncology | ||||||
| 09/17/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: BioOncology | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $15.49 | General |
| 09/10/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.96 | General |
| 07/26/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Hematology | ||||||
| 07/24/2024 | Genentech USA, Inc. | Kadcyla (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: BioOncology | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $10.45 | General |
| 07/22/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 40 | $6,310 | $1,521 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $4,825 | $1,149 | 23.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,485 | $372.15 | 25.1% |
About Renay Smith, APRN
Renay Smith, APRN is a Infusion Therapy healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1053977538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Renay Smith, APRN has received a total of $2,662 in payments from pharmaceutical and medical device companies, with $1,360 received in 2024. These payments were reported across 108 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,462).
As a Medicare-enrolled provider, Smith has provided services to 39 Medicare beneficiaries, totaling 40 services with total Medicare billing of $1,521. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Infusion Therapy
- Other Specialties Family
- Location Miami, FL
- Active Since 05/10/2019
- Last Updated 07/12/2019
- Taxonomy Code 163WI0500X
- Entity Type Individual
- NPI Number 1053977538
Products in Payments
- DARZALEX (Biological) $211.90
- Enhertu (Drug) $183.35
- RYBREVANT (Drug) $181.74
- Blincyto (Biological) $151.20
- SARCLISA (Biological) $98.13
- KEYTRUDA (Biological) $80.26
- ZEPZELCA (Drug) $77.93
- Zoladex (Drug) $70.64
- Phesgo (Biological) $64.97
- Lenvima (Drug) $59.61
- Epkinly (Drug) $56.94
- JAKAFI (Drug) $56.45
- Venclexta (Biological) $51.35
- ENHERTU (Biological) $50.11
- Columvi (Biological) $46.01
- ERLEADA (Drug) $43.39
- CARVYKTI (Drug) $38.40
- PIQRAY (Drug) $33.28
- Elahere (Biological) $29.86
- PLUVICTO (Drug) $27.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infusion Therapy Doctors in Miami
Dr. Roberto Gomara
Infusion Therapy — Payments: $3,969
Laura Saldivar
Infusion Therapy — Payments: $152.90
Eduardo Limas Musa, Dnp, DNP
Infusion Therapy — Payments: $18.50
Nicolette Acosta, Rn, RN
Infusion Therapy
Yitsy Arguelles
Infusion Therapy